Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls—a pilot study

Psychopharmacology

Volumn 233, Issue 11, 2016, Pages 2109-2117

  Timby, Erika ^a   Bäckström, Torbjörn ^a   Nyberg, Sigrid ^a   Stenlund, Hans ^a   Wihlbäck, Anna Carin N ^a   Bixo, Marie ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

GABA; Menstrual cycle; Neurosteroid; Premenstrual dysphoric disorder; Saccadic eye velocity

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; ELTANOLONE; HYPNOTIC SEDATIVE AGENT; SEX HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG SENSITIVITY; ELECTROOCULOGRAPHY; EXPERIMENTAL STUDY; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN CELL; LUTEAL PHASE; MENSTRUAL CYCLE; OUTCOME ASSESSMENT; PILOT STUDY; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SACCADIC EYE MOVEMENT; SACCADIC EYE VELOCITY; SEDATION; SINGLE DRUG DOSE; TREATMENT RESPONSE; ADOLESCENT; ANXIETY; BLOOD; COMPARATIVE STUDY; DRUG EFFECTS; PANIC; PATHOPHYSIOLOGY; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANXIETY; ELECTROOCULOGRAPHY; FEMALE; GABA MODULATORS; GONADAL STEROID HORMONES; HUMANS; HYPNOTICS AND SEDATIVES; MENSTRUAL CYCLE; PANIC; PILOT PROJECTS; PREGNANOLONE; PREMENSTRUAL DYSPHORIC DISORDER; RECEPTORS, GABA-A; SACCADES; YOUNG ADULT;

EID: 84960465338     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-016-4258-1     Document Type: Article

References (65)

1. Akwa Y, Purdy RH, Koob GF, Britton KT (1999) The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res 106:119–125
2. Andreen L, Sundstrom-Poromaa I, Bixo M, Nyberg S, Backstrom T (2006) Allopregnanolone concentration and mood—a bimodal association in postmenopausal women treated with oral progesterone. Psychopharmacology (Berlin) 187:209–221
3. APA (2013) The diagnostic and statistical manual of mental disorders. American Psychiatric Association, Arlington
4. Backstrom T, Andreen L, Birzniece V, Bjorn I, Johansson IM, Nordenstam-Haghjo M, Nyberg S, Sundstrom-Poromaa I, Wahlstrom G, Wang M, Zhu D (2003) The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs 17:325–342
5. Backstrom T, Haage D, Lofgren M, Johansson IM, Stromberg J, Nyberg S, Andreen L, Ossewaarde L, van Wingen GA, Turkmen S, Bengtsson SK (2011) Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons. Neuroscience 191:46–54
6. Backstrom T, Bixo M, Johansson M, Nyberg S, Ossewaarde L, Ragagnin G, Savic I, Stromberg J, Timby E, van Broekhoven F, van Wingen G (2014) Allopregnanolone and mood disorders. Prog Neurobiol 113:88–94
7. Ball DM, Glue P, Wilson S, Nutt DJ (1991) Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil. Psychopharmacology (Berlin) 105:361–367
8. Bell EC, Baker GB, Poag C, Bellavance F, Khudabux J, Le Melledo JM (2004) Response to flumazenil in the late luteal phase and follicular phase of the menstrual cycle in healthy control females. Psychopharmacology (Berlin) 172:248–254
9. Ben-Porath DD, Taylor SP (2002) The effects of diazepam (valium) and aggressive disposition on human aggression: an experimental investigation. Addict Behav 27:167–177
10. Birzniece V, Turkmen S, Lindblad C, Zhu D, Johansson IM, Backstrom T, Wahlstrom G (2006) GABA(A) receptor changes in acute allopregnanolone tolerance. Eur J Pharmacol 535:125–134
11. Bixo M, Andersson A, Winblad B, Purdy RH, Backstrom T (1997) Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res 764:173–178
12. Buhrer M, Maitre PO, Crevoisier C, Stanski DR (1990) Electroencephalographic effects of benzodiazepines. II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam. Clin Pharmacol Ther 48:555–567
13. Chan AF, Mortola JF, Wood SH, Yen SS (1994) Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486. Obstet Gynecol 84:1001–1005
14. Dougherty DM, Cherek DR, Bennett RH (1996) The effects of alcohol on the aggressive responding of women. J Stud Alcohol 57:178–186
15. Epperson CN, Haga K, Mason GF, Sellers E, Gueorguieva R, Zhang W, Weiss E, Rothman DL, Krystal JH (2002) Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 59:851–858
16. Fernandez G, Weis S, Stoffel-Wagner B, Tendolkar I, Reuber M, Beyenburg S, Klaver P, Fell J, de Greiff A, Ruhlmann J, Reul J, Elger CE (2003) Menstrual cycle-dependent neural plasticity in the adult human brain is hormone, task, and region specific. J Neurosci 23:3790–3795
17. Follesa P, Porcu P, Sogliano C, Cinus M, Biggio F, Mancuso L, Mostallino MC, Paoletti AM, Purdy RH, Biggio G, Concas A (2002) Changes in GABAA receptor gamma 2 subunit gene expression induced by long-term administration of oral contraceptives in rats. Neuropharmacology 42:325–336
18. Frye CA (1995) The neurosteroid 3 alpha, 5 alpha-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res 696:113–120
19. Gingnell M, Ahlstedt V, Bannbers E, Wikstrom J, Sundstrom-Poromaa I, Fredrikson M (2014) Social stimulation and corticolimbic reactivity in premenstrual dysphoric disorder: a preliminary study. Biol Mood Anxiety Disord 4:3
20. Hommer DW, Matsuo V, Wolkowitz O, Chrousos G, Greenblatt DJ, Weingartner H, Paul SM (1986) Benzodiazepine sensitivity in normal human subjects. Arch Gen Psychiatry 43:542–551
21. Iacono WG, Lykken DT (1981) Two-year retest stability of eye tracking performance and a comparison of electro-oculographic and infrared recording techniques: evidence of EEG in the electro-oculogram. Psychophysiology 18:49–55
22. Lambert JJ, Belelli D, Harney SC, Peters JA, Frenguelli BG (2001) Modulation of native and recombinant GABA(A) receptors by endogenous and synthetic neuroactive steroids. Brain Res Brain Res Rev 37:68–80
23. Lovick TA, Griffiths JL, Dunn SM, Martin IL (2005) Changes in GABA(A) receptor subunit expression in the midbrain during the oestrous cycle in Wistar rats. Neuroscience 131:397–405
24. Maguire JL, Stell BM, Rafizadeh M, Mody I (2005) Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci 8:797–804
25. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM (1986) Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232:1004–1007
26. Martinez PE, Rubinow DR, Nieman LK, Koziol DE, Morrow AL, Schiller CE, Cintron D, Thompson KD, Khine KK, Schmidt PJ (2016) 5alpha-Reductase inhibition prevents the luteal phase increase in plasma allopregnanolone levels and mitigates symptoms in women with premenstrual dysphoric disorder. Neuropsychopharmacology 41:1093–1102
27. Miczek KA, Fish EW, De Bold JF, De Almeida RM (2002) Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems. Psychopharmacology (Berlin) 163:434–458
28. Miczek KA, Fish EW, De Bold JF (2003) Neurosteroids, GABAA receptors, and escalated aggressive behavior. Horm Behav 44:242–257
29. Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M, Petraglia F, Genazzani AR (2000) Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 142:269–273
30. Norberg L, Backstrom T, Wahlstrom G (1999) Anaesthetic effects of pregnanolone in combination with allopregnanolone, thiopental, hexobarbital and flurazepam: an EEG study in the rat. Br J Anaesth 82:731–737
31. Nyberg S, Wahlstrom G, Backstrom T, Sundstrom Poromaa I (2004) Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder. Psychoneuroendocrinology 29:767–777
32. O’Brien PM, Backstrom T, Brown C, Dennerstein L, Endicott J, Epperson CN, Eriksson E, Freeman E, Halbreich U, Ismail KM, Panay N, Pearlstein T, Rapkin A, Reid R, Schmidt P, Steiner M, Studd J, Yonkers K (2011) Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health 14:13–21
33. Ossewaarde L, van Wingen GA, Kooijman SC, Backstrom T, Fernandez G, Hermans EJ (2011) Changes in functioning of mesolimbic incentive processing circuits during the premenstrual phase. Soc Cogn Affect Neurosci 6:612–620
34. Pearlstein T (2007) Prevalence, impact on morbidity and burden of disease. In: O’Brian PM, Rapkin A, Schmidt PS (eds) The premenstrual syndromes: PMS and PMDD. Informa Healthcare, London, pp 37–47
35. Pearlstein T (2012) Psychotropic medications and other non-hormonal treatments for premenstrual disorders. Menopause Int 18:60–64
36. Peterson RA, Reiss S (1992) Anxiety sensitivity index manual. In: International diagnostic system, Worthington, OH
37. Protopopescu X, Pan H, Altemus M, Tuescher O, Polanecsky M, McEwen B, Silbersweig D, Stern E (2005) Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle. Proc Natl Acad Sci U S A 102:16060–16065
38. Protopopescu X, Tuescher O, Pan H, Epstein J, Root J, Chang L, Altemus M, Polanecsky M, McEwen B, Stern E, Silbersweig D (2008) Toward a functional neuroanatomy of premenstrual dysphoric disorder. J Affect Disord 108:87–94
39. Purdy RH, Moore PH Jr, Rao PN, Hagino N, Yamaguchi T, Schmidt P, Rubinow DR, Morrow AL, Paul SM (1990) Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma. Steroids 55:290–296
40. Radu D, Ahlin A, Svanborg P, Lindefors N (2002) Anxiogenic effects of the CCK(B) agonist pentagastrin in humans and dose-dependent increase in plasma C-peptide levels. Psychopharmacology (Berlin) 161:396–403
41. Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone D, Mahesh VB (1997) Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 90:709–714
42. Rapkin AJ, Berman SM, Mandelkern MA, Silverman DH, Morgan M, London ED (2011) Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder. Biol Psychiatry 69:374–380
43. Savic I, Widen L, Stone-Elander S (1991) Feasibility of reversing benzodiazepine tolerance with flumazenil. Lancet 337:133–137
44. Schmidt PJ, Nieman LK, Grover GN, Muller KL, Merriam GR, Rubinow DR (1991) Lack of effect of induced menses on symptoms in women with premenstrual syndrome. N Engl J Med 324:1174–1179
45. Schmidt PJ, Purdy RH, Moore PH Jr, Paul SM, Rubinow DR (1994) Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab 79:1256–1260
46. Segebladh B, Borgstrom A, Nyberg S, Bixo M, Sundstrom-Poromaa I (2009) Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder. Am J Obstet Gynecol 201(139):e131–e138
47. Smith MJ, Adams LF, Schmidt PJ, Rubinow DR, Wassermann EM (2003) Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome. Biol Psychiatry 54:757–762
48. Spielberger (1970) Manual for the State-Trait Anxiety Inventory. Consulting Psychology Press, Palo Alto
49. Sundstrom I, Nyberg S, Backstrom T (1997) Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology 17:370–381
50. Sundstrom I, Andersson A, Nyberg S, Ashbrook D, Purdy RH, Backstrom T (1998) Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 67:126–138
51. Timby E, Balgard M, Nyberg S, Spigset O, Andersson A, Porankiewicz-Asplund J, Purdy RH, Zhu D, Backstrom T, Poromaa IS (2006) Pharmacokinetic and behavioral effects of allopregnanolone in healthy women. Psychopharmacology (Berlin) 186:414–424
52. Toffoletto S, Lanzenberger R, Gingnell M, Sundstrom-Poromaa I, Comasco E (2014) Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: a systematic review. Psychoneuroendocrinology 50:28–52
53. Turkmen S, Lundgren P, Birzniece V, Zingmark E, Backstrom T, Johansson IM (2004) 3beta-20beta-dihydroxy-5alpha-pregnane (UC1011) antagonism of the GABA potentiation and the learning impairment induced in rats by allopregnanolone. Eur J Neurosci 20:1604–1612
54. Turkmen S, Backstrom T, Wahlstrom G, Andreen L, Johansson IM (2011) Tolerance to allopregnanolone with focus on the GABA-A receptor. Br J Pharmacol 162:311–327
55. Uusi-Oukari M, Korpi ER (2010) Regulation of GABA(A) receptor subunit expression by pharmacological agents. Pharmacol Rev 62:97–135
56. van Broekhoven F, Backstrom T, van Luijtelaar G, Buitelaar JK, Smits P, Verkes RJ (2007) Effects of allopregnanolone on sedation in men, and in women on oral contraceptives. Psychoneuroendocrinology 32:555–564
57. van Wingen G, van Broekhoven F, Verkes RJ, Petersson KM, Backstrom T, Buitelaar J, Fernandez G (2007) How progesterone impairs memory for biologically salient stimuli in healthy young women. J Neurosci 27:11416–11423
58. van Wingen GA, Ossewaarde L, Backstrom T, Hermans EJ, Fernandez G (2011) Gonadal hormone regulation of the emotion circuitry in humans. Neuroscience 191:38–45
59. Wang M, Seippel L, Purdy RH, Backstrom T (1996) Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 81:1076–1082
60. Weinbroum AA, Szold O, Ogorek D, Flaishon R (2001) The midazolam-induced paradox phenomenon is reversible by flumazenil. Epidemiology, patient characteristics and review of the literature. Eur J Anaesthesiol 18:789–797
61. West BT, Welch KB, Galecki AT (2007) Linear mixed models. Chapman & Hall, Boca Ruton
62. Wong PT, Yoong YL, Gwee MC (1986) Acute tolerance to diazepam induced by benzodiazepines. Clin Exp Pharmacol Physiol 13:1–8
63. Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O’Brien PM (2004) The effectiveness of GnRHa with and without ‘add-back’ therapy in treating premenstrual syndrome: a meta analysis. BJOG 111:585–593
64. Zhu D, Wang MD, Backstrom T, Wahlstrom G (2001) Evaluation and comparison of the pharmacokinetic and pharmacodynamic properties of allopregnanolone and pregnanolone at induction of anaesthesia in the male rat. Br J Anaesth 86:403–412
65. Zhu D, Birzniece V, Backstrom T, Wahlstrom G (2004) Dynamic aspects of acute tolerance to allopregnanolone evaluated using anaesthesia threshold in male rats. Br J Anaesth 93:560–567